Nanoparticles as potential clinical therapeutic agents in Alzheimer’s disease: focus on selenium nanoparticles
Introduction: In etiology of Alzheimer’s disease (AD), involvement of amyloid β (Aβ) plaque accumulation and oxidative stress in the brain have important roles. Several nanoparticles such as titanium dioxide, silica dioxide, silver and zinc oxide have been experimentally using for treatment of neuro...
Published in: | Expert Review of Clinical Pharmacology |
---|---|
Main Author: | 2-s2.0-85021103809 |
Format: | Review |
Language: | English |
Published: |
Taylor and Francis Ltd
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021103809&doi=10.1080%2f17512433.2017.1324781&partnerID=40&md5=c4279183e800673b1cd805c82ffadca3 |
Similar Items
-
Exploration of synthetic multifunctional amides as new therapeutic agents for Alzheimer's disease through enzyme inhibition, chemoinformatic properties, molecular docking and dynamic simulation insights
by: 2-s2.0-85053905014
Published: (2018) -
Synthesis, enzyme inhibitory kinetics mechanism and computational study of N-(4-methoxyphenethyl)-N-(substituted)- 4-methylbenzenesulfonamides as novel therapeutic agents for Alzheimer's disease
by: 2-s2.0-85049259205
Published: (2018) -
Synthesis, biological evaluation, molecular docking and dynamic simulation of novel benzofuran derivatives as potential agents against Alzheimer's disease
by: 2-s2.0-85206074124
Published: (2025) -
Synthesis of Some New N-Alkyl/Aralkyl-N-(2,3-Dihydro-1,4-Benzodioxin-6-YL)-4-Bromobenzenesulfonamides as Possible Therapeutic Agents F or Alzheimer’s Disease
by: 2-s2.0-85127408369
Published: (2022) -
Synthesis, biological and computational evaluation of benzoxazole hybrid analogs as potential anti-Alzheimer's agents
by: 2-s2.0-85204151475
Published: (2024)